Abstract
Cardiopulmonar complications in chronic liver diseases were described 100 years ago. Altough both hepatopulmonary sindrome and portopulmonary hypertension originates from liver damage, clinical findings and diagnosis are very different. These complications are important due to the highly deleterous impact on disease evolution and prognosis. Currently, there is not an ideal treatment for these diseases and liver transplantation should be adequately evaluated. In this review we analyze the most important issues on hepatopulmonary sindrome and portopulmonary hypertension. These complications,under the cornerstone of portal hypertension are characterized by pulmonary constriction and dilatation, respectively.
MeSH terms
-
Adult
-
Algorithms
-
Child
-
Clinical Trials as Topic
-
Echocardiography
-
Female
-
Hepatopulmonary Syndrome* / diagnosis
-
Hepatopulmonary Syndrome* / diagnostic imaging
-
Hepatopulmonary Syndrome* / drug therapy
-
Hepatopulmonary Syndrome* / epidemiology
-
Hepatopulmonary Syndrome* / etiology
-
Hepatopulmonary Syndrome* / physiopathology
-
Hepatopulmonary Syndrome* / therapy
-
Humans
-
Hypertension, Portal* / diagnosis
-
Hypertension, Portal* / drug therapy
-
Hypertension, Portal* / epidemiology
-
Hypertension, Portal* / etiology
-
Hypertension, Portal* / physiopathology
-
Hypertension, Portal* / therapy
-
Hypertension, Pulmonary* / diagnosis
-
Hypertension, Pulmonary* / drug therapy
-
Hypertension, Pulmonary* / epidemiology
-
Hypertension, Pulmonary* / etiology
-
Hypertension, Pulmonary* / physiopathology
-
Hypertension, Pulmonary* / therapy
-
Liver Cirrhosis / complications*
-
Liver Cirrhosis / physiopathology
-
Liver Transplantation
-
Male
-
Portasystemic Shunt, Transjugular Intrahepatic
-
Prevalence
-
Prognosis
-
Pulmonary Artery / physiopathology
-
Pulmonary Circulation
-
Vasoconstriction / physiology
-
Vasodilation / physiology